ArticleNephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association2019

Pro: Tolvaptan delays the progression of autosomal dominant polycystic kidney disease.

Vicente E TorresPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.